[arcticbull]

I was speculating about the role of Azithromycin though it appears another peer post mentioned something similar. The study was only 28 patients, open-label, non-randomized, 6 of which were asymptomatic. I think it's too early to say one way or the other, the N is really small on the study.

It could easily have been that some patients in the study developed bacterial pneumonia secondary to their COVID-19 and the azithromycin treated it. Much too early to say.

> Maybe you could clarify something else for me. Is there any information about whether these two drugs together could function as a prophylactic, or is this something patients have to be administered at the beginning of symptoms, or is this something that can be done late in the course of the disease?

Wish I knew, seems to be something we'll hear more about in the near term given the interest in studying it. From what I read it works best in early stages of disease and not as well later on. While not side-effect free, they're pretty highly targeted.